Allergan

Ideal Image Appoints Dr. Tara Margarella as Chief Medical Officer

Retrieved on: 
Wednesday, September 6, 2023

Ideal Image , North America’s #1 medical aesthetics provider, today announced the appointment of Tara Margarella, D.O., as Chief Medical Officer.

Key Points: 
  • Ideal Image , North America’s #1 medical aesthetics provider, today announced the appointment of Tara Margarella, D.O., as Chief Medical Officer.
  • In her new role, she will lead Ideal Image’s innovation pipeline and medical team, reporting directly to CEO Sharon Leite.
  • “Her experience supporting fast-growth aesthetics product companies will be invaluable as we cement our position as an industry innovator and expand our portfolio of products and services to offer a best-in-class customer experience.”
    As Chief Medical Officer, Dr. Margarella will lead Ideal Image’s Medical Board, overseeing the company’s Medical Affairs and Medical Operations Education teams.
  • “By harnessing innovation across our aesthetics treatments and services, we will continue to deliver an unmatched and personalized experience to every Ideal Image customer.”
    Before joining Ideal Image, Dr. Margarella served as a senior medical director and medical affairs leader.

Monaghan Medical Corp Takes Direct Control of Aerochamber® Brand Valved Holding Chamber (VHC) in Retail Pharmacy Market

Retrieved on: 
Tuesday, September 5, 2023

PLATTSBURGH, N.Y., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Monaghan Medical Corporation (Monaghan) and Allergan Sales, LLC have announced a mutual agreement wherein Monaghan will assume the direct management of the AeroChamber® brand Valved Holding Chamber (VHC) for retail pharmacy markets.

Key Points: 
  • PLATTSBURGH, N.Y., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Monaghan Medical Corporation (Monaghan) and Allergan Sales, LLC have announced a mutual agreement wherein Monaghan will assume the direct management of the AeroChamber® brand Valved Holding Chamber (VHC) for retail pharmacy markets.
  • Starting January 1, 2024, Monaghan will take on the complete responsibility for retail pharmacy sales of the AeroChamber® brand VHC.
  • Commencing from September 1, 2023, Monaghan will initiate collaborations with pharmacy wholesalers and retail establishments that currently procure the AeroChamber® brand VHC through Allergan, manufactured by Monaghan.

Western Dermatology Consultants Welcomes New Members and Launches New Website

Retrieved on: 
Monday, August 21, 2023

The practice is also excited to welcome the newest additions to their team: esthetician Christy Garcia and nurse injector Olivia Salinas, BSN, RN.

Key Points: 
  • The practice is also excited to welcome the newest additions to their team: esthetician Christy Garcia and nurse injector Olivia Salinas, BSN, RN.
  • With a passion for beauty, skincare, and wellness, she aims to provide the most attentive and personalized care for patients.
  • Patients can receive comprehensive diagnosis, care, and treatment for common conditions such as acne, scarring, dry skin, skin cancer, and nail fungus.
  • For more information about medical and cosmetic dermatology, contact Western Dermatology Consultants.

Arcutis Appoints Interim Chief Financial Officer (CFO)

Retrieved on: 
Friday, August 18, 2023

WESTLAKE VILLAGE, Calif., Aug. 18, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that John W. Smither, who served as Arcutis’ first Chief Financial Officer (CFO) from 2019 to 2021, has been appointed interim CFO effective August 31.

Key Points: 
  • WESTLAKE VILLAGE, Calif., Aug. 18, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that John W. Smither, who served as Arcutis’ first Chief Financial Officer (CFO) from 2019 to 2021, has been appointed interim CFO effective August 31.
  • “We are delighted that John has agreed to step in as interim CFO.
  • He brings an incredible depth and breadth of both financial acumen and dermatology experience from his 25+-year career in the pharmaceutical industry, culminating in five successive CFO roles including his previous stint at Arcutis,” said Frank Watanabe, President and Chief Executive Officer of Arcutis.
  • “On behalf of our Board and team, I would like to thank Scott for his tremendous contributions to Arcutis.

Competitive Landscape in 2023 Conjunctivitis Treatment Market Features Key Players like Novartis, Allergan, and More - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 17, 2023

The conjunctivitis treatment market is expected to register a CAGR of 4.1% over the forecast period.

Key Points: 
  • The conjunctivitis treatment market is expected to register a CAGR of 4.1% over the forecast period.
  • Thus the incidence of allergic conjunctivitis is expected to contribute to the market's growth during the forecast period.
  • The rising incidence of hemorrhagic conjunctivitis is expected to drive the demand for conjunctivitis treatment, thereby contributing to market growth.
  • The conjunctivitis treatment market is moderately consolidated in nature due to the presence of several companies operating globally as well as regionally.

Bausch + Lomb Solidifies Leadership Team

Retrieved on: 
Tuesday, August 1, 2023

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced changes to its executive leadership team including the creation of two new roles.

Key Points: 
  • Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced changes to its executive leadership team including the creation of two new roles.
  • The moves build on a reshuffling announced in early June after Chairman and CEO Brent Saunders, who previously served as CEO from 2010 to 2013, rejoined Bausch + Lomb.
  • “Seizing the opportunity in front of us means acting swiftly, which is why I’ve been so focused on establishing a refreshed leadership team,” said Saunders.
  • Gevgilili is currently chief human resources officer at INOVIO Pharmaceuticals and previously held human resources leadership roles at Allergan, Merck and Merrill Lynch.

Newsweek Names Dr. Brian K. Reedy of Berks Plastic Surgery One of America's Best Plastic Surgeons for 2023

Retrieved on: 
Tuesday, August 1, 2023

WYOMISSING, Pa., Aug. 1, 2023 /PRNewswire/ -- Dr. Brian K. Reedy of Berks Plastic Surgery has been recognized as one of the nation's top plastic surgeons by Newsweek magazine for the third consecutive year. In addition to liposuction, Dr. Reedy has also been awarded for breast augmentation in previous years. The "America's Best Plastic Surgeon 2023" rankings were determined by evaluations from fellow plastic surgeons and other medical experts in the field and awarded based on the number of recommendations, additional quality assessments, and proof of relevant certifications.

Key Points: 
  • The highly sought-after Berks County, PA plastic surgeon was recognized as one of the top liposuction surgeons in the country
    WYOMISSING, Pa., Aug. 1, 2023 /PRNewswire/ -- Dr. Brian K. Reedy of Berks Plastic Surgery has been recognized as one of the nation's top plastic surgeons by Newsweek magazine for the third consecutive year.
  • In addition to liposuction, Dr. Reedy has also been awarded for breast augmentation in previous years.
  • The "America's Best Plastic Surgeon 2023" rankings were determined by evaluations from fellow plastic surgeons and other medical experts in the field and awarded based on the number of recommendations, additional quality assessments, and proof of relevant certifications.
  • "It's an honor to have my skills recognized by my peers and Newsweek," said Dr. Reedy.

Medical Aesthetics Market size worth $ 27.55 Billion, Globally, by 2028 at 10.6% CAGR: Verified Market Research®

Retrieved on: 
Monday, July 24, 2023

JERSEY CITY, N.J, July 24, 2023 /PRNewswire/ -- The Global Medical Aesthetics Market is projected to grow at a CAGR of 10.6% from 2021 to 2028, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 11.41 Billion in 2020 and is expected to reach USD 27.55 Billion by the end of the forecast period.

Key Points: 
  • The "Global Medical Aesthetics Market Size By Product, By End User, By Geographic Scope And Forecast" report has been published by Verified Market Research®.
  • The report provides an in-depth analysis of the global Medical Aesthetics Market, including its growth prospects, market trends, and market challenges.
  • For more information, financial statements, product benchmarking, and SWOT analysis, on the Global Medical Aesthetics Market, please purchase Medical Aesthetics Market report at Verified Market Research .
  • Based on the research, Verified Market Research® has segmented the global Medical Aesthetics Market into Product, End User, And Geography.

Medical Aesthetics Market size worth $ 27.55 Billion, Globally, by 2028 at 10.6% CAGR: Verified Market Research®

Retrieved on: 
Monday, July 24, 2023

JERSEY CITY, N.J, July 24, 2023 /PRNewswire/ -- The Global Medical Aesthetics Market is projected to grow at a CAGR of 10.6% from 2021 to 2028, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 11.41 Billion in 2020 and is expected to reach USD 27.55 Billion by the end of the forecast period.

Key Points: 
  • The "Global Medical Aesthetics Market Size By Product, By End User, By Geographic Scope And Forecast" report has been published by Verified Market Research®.
  • The report provides an in-depth analysis of the global Medical Aesthetics Market, including its growth prospects, market trends, and market challenges.
  • For more information, financial statements, product benchmarking, and SWOT analysis, on the Global Medical Aesthetics Market, please purchase Medical Aesthetics Market report at Verified Market Research .
  • Based on the research, Verified Market Research® has segmented the global Medical Aesthetics Market into Product, End User, And Geography.

Amarin Appoints Patrick Holt as President and Chief Executive Officer

Retrieved on: 
Tuesday, July 18, 2023

DUBLIN, Ireland and BRIDGEWATER, N.J., July 18, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced that the Company’s Board of Directors has appointed Patrick Holt as President and Chief Executive Officer and as a member of the Board of Directors, effective immediately.

Key Points: 
  • DUBLIN, Ireland and BRIDGEWATER, N.J., July 18, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced that the Company’s Board of Directors has appointed Patrick Holt as President and Chief Executive Officer and as a member of the Board of Directors, effective immediately.
  • Aaron Berg, who served as Interim President and CEO since April 2023, will remain with the Company in a senior leadership role.
  • Mr. Holt brings more than 25 years of leadership in the life sciences industry and significant international operating experience.
  • Mr. Holt previously held a variety of senior executive positions across biopharmaceuticals and vaccines at Allergan and Merck.